Zydus receives USFDA approval for Famotidine Injection

30 Nov 2022 , 01:35 AM

Zydus Lifesciences has received final approval from the United States Food and Drug Administration USFDA to market Famotidine Injection USP 40 mg4 mL 10 mgmL and 200 mg20 mL 10 mgmL multiple-dose vials USRLD Pepcid injection Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed This medication is also used to treat certain stomach and throat esophagus problems such as erosive esophagitis gastroesophageal reflux disease-GERD and Zollinger-Ellison syndrome Famotidine Injection had annual sales of USD 19 mn in the United States according to IQVIA data IQVIA MAT Sep 2022 The drug will be manufactured at the groups injectable manufacturing facility at Jarod near Vadodara India